HomeNewsBusinessCompaniesCoronavirus pandemic | Say goodbye to salary hikes for now
Trending Topics

Coronavirus pandemic | Say goodbye to salary hikes for now

Cost saving is the primary focus among Indian companies as they grapple with revenue downfall due to the COVID-19 outbreak.

April 07, 2020 / 14:53 IST
Story continues below Advertisement

Just two weeks before Mahesh Subramanian was hoping to receive a 15 percent salary hike and a Rs 35,000 performance bonus. On April 7, a mail hit his inbox informing him of the ‘tough economic condition’. The offshore centre (or global in-house centre) he was working for in Hyderabad informed him that the appraisal process would be delayed till mid-September.

The novel coronavirus (or COVID-19) pandemic has led to a lockdown across the country. Amid this, the glimmer of hope for annual appraisals have also dimmed with companies deferring any hike till further notice. While hikes were anyways expected to be muted, with threats of a slowdown since January, a few sectors like e-commerce, retail, digital marketing and ITeS were expected to be outliers.

Story continues below Advertisement

Global in-house centres (GICs) were expected to offer the highest level of hikes to Indian employees. GICs are offshore centre that perform servicing functions for large multinationals. India has more than 1,000 GICs that have set up to leverage the country’s highly-skilled and low-cost talent pool.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show